D
DexCom, Inc. (DXCM)
NMS – Real vaqt narxi. Valyuta: USD
61.14
+1.81 (3.05%)
Yopilishda: May 12, 2026, 4:00 PM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
Find any stock by ticker or company name
NMS – Real vaqt narxi. Valyuta: USD
61.14
+1.81 (3.05%)
Yopilishda: May 12, 2026, 4:00 PM EDT
DexCom, Inc., tibbiy uskunalar ishlab chiqaruvchi kompaniya, Qo'shma Shtatlar va xalqaro miqyosda diabet va metabolik salomatlikni boshqarish uchun uzluksiz glyukoza monitoringi (CGM) tizimlarini loyihalash, ishlab chiqish va tijoratlashtirishga qaratilgan. Kompaniya diabetni davolash qarorlari uchun barmoqdan qon glyukoza testini almashtirish uchun Dexcom G7 va G7 15 Day - integratsiyalashgan uzluksiz glyukoza monitoringi tizimini; Dexcom G6 - CGM tizimini; Dexcom ONE+ ni taklif etadi; insulin ishlatmaydigan prediabet va 2-toifa diabetga chalingan kattalar uchun mo'ljallangan biosensor Stelo; masofaviy monitoring tizimi bo'lgan Dexcom Share; va Dexcom Follow ilovasini taqdim etadi. Kompaniya o'z mahsulotlarini to'g'ridan-to'g'ri endokrinologlar, shifokorlar va diabet ta'limchilari orasida sotadi. Kompaniya 1999 yilda tashkil etilgan va shtab-kvartirasi San-Diego, Kaliforniyada joylashgan.
| Ism | Lavozim |
|---|---|
| Mr. Donald M. Abbey | Executive Vice President of Global Business Services, Regulatory, Medical & Clinical Affairs |
| Mr. Girish Naganathan | Executive VP & CTO |
| Mr. Jacob Steven Leach | President, CEO & Director |
| Mr. Jereme M. Sylvain CPA | Executive VP, CFO & Chief Accounting Officer |
| Mr. Jon Coleman | Executive VP & Chief Commercial Officer |
| Mr. Kevin Ronald Sayer | Executive Chairman of the Board |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-04-30 | 10-Q | dxcm-20260331.htm |
| 2026-04-15 | DEFA14A | dxcm-defa14a2026xnaa.htm |
| 2026-04-15 | DEF 14A | dxcm-20260415.htm |
| 2026-04-15 | ARS | dxcm2025_ars.pdf |
| 2026-03-02 | 8-K | dxcm-20260227.htm |
| 2026-02-12 | 10-K | dxcm-20251231.htm |
| 2026-01-12 | 8-K | dxcm-20260107.htm |
| 2025-12-22 | 8-K | dxcm-20251219.htm |
| 2025-10-30 | 10-Q | dxcm-20250930.htm |
| 2025-10-27 | 8-K | dxcm-20251024.htm |
| Mr. Matthew Dolan | Executive Vice President of Strategy & Corporate Development |
| Mr. Michael Jon Brown J.D. | Executive VP & Chief Legal Officer |
| Mr. Sean Christensen | Vice President of Finance and Investor Relations |
| Ms. Sadie M. Stern | Executive VP & Chief Human Resources Officer |